Arrowhead Pharmaceuticals (ARWR) Other Working Capital Changes (2010 - 2026)
Arrowhead Pharmaceuticals (ARWR) posted Other Working Capital Changes of -$2.4 million for Q1 2026, down 10295.83% on a QoQ basis from $24000.0 in Q4 2025, and down 105.66% year-over-year from $43.3 million in Q1 2025.
Arrowhead Pharmaceuticals (ARWR) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Arrowhead Pharmaceuticals' Other Working Capital Changes history runs 10 years deep, the most recent figure standing at -$2.4 million for Q1 2026.
- Quarterly Other Working Capital Changes fell 105.66% year-over-year to -$2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$43.3 million (down 197.36% YoY) and the FY2025 annual result came in at $2.4 million, up 99.92% from the prior year.
- Other Working Capital Changes was -$2.4 million for Q1 2026 at Arrowhead Pharmaceuticals, down from $24000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $20.3 million in Q1 2025 and bottomed at -$12.4 million in Q3 2025.
- A 5-year average of $1.6 million and a median of $895000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes sank 10090.87% — and 2023, when it soared 728.85%.
- Arrowhead Pharmaceuticals' Other Working Capital Changes stood at -$23.0 million in 2022, then surged by 795.13% to $159.7 million in 2023, then sank by 99.25% to $1.2 million in 2024, then slumped by 98.0% to $24000.0 in 2025, then slumped by 10295.83% to -$2.4 million in 2026.
- Business Quant data shows ARWR's Other Working Capital Changes at -$2.4 million in Q1 2026, $24000.0 in Q4 2025, and -$20.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arrowhead Pharmaceuticals | 11.98 Bn | 10.18 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.77 Mn |
| Mar 31, 2026 | -4.77 Mn |
| Mar 31, 2026 | -4.77 Mn |
| Dec 31, 2025 | 13.18 Mn |
| Dec 31, 2025 | 13.18 Mn |
| Dec 31, 2025 | 13.18 Mn |
| Sep 30, 2025 | -12.40 Mn |
| Sep 30, 2025 | -12.40 Mn |
| Sep 30, 2025 | -12.40 Mn |
| Jun 30, 2025 | 1.41 Mn |
| Jun 30, 2025 | 1.41 Mn |
| Jun 30, 2025 | 1.41 Mn |
| Mar 31, 2025 | 20.34 Mn |
| Mar 31, 2025 | 20.34 Mn |
| Mar 31, 2025 | 20.34 Mn |
| Dec 31, 2024 | 592,000.00 |
| Dec 31, 2024 | 592,000.00 |
| Dec 31, 2024 | 592,000.00 |
| Sep 30, 2024 | -82,000.00 |
| Sep 30, 2024 | -82,000.00 |